Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nature Medicine

• Publication date

  2003-08-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nm909PMID 12897778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Acute Myeloid Leukemia Cells Bind to Bone Marrow Stroma Via a Combination of /3-1 and /3-2 Integrin Mechanisms

  2003cited by this paper
• Comparing the importance of prognostic factors in Cox and logistic regression using SAS

  2003cited by this paper
• Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells.

  2003cited by this paper
• Induction of heat shock protein 47 synthesis by TGF-beta and IL-1 beta via enhancement of the heat shock element binding activity of heat shock transcription factor 1.

  2002cited by this paper
• Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines.

  2002cited by this paper
• Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation1

  2002cited by this paper
• Differentiative potential of human metanephric mesenchymal cells.

  2002cited by this paper
• Induction of Heat Shock Protein 47 Synthesis by TGF-β and IL-1β Via Enhancement of the Heat Shock Element Binding Activity of Heat Shock Transcription Factor 1

  2002cited by this paper
• Matrix Attachment Regulates FAS-Induced Apoptosis in Endothelial Cells

  2001cited by this paper
• Effects of anti-CD 44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines

  2001cited by this paper
• Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells

  2001cited by this paper
• Cross-talk between α4β1/α5β1 and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways

  2001cited by this paper
• Cross-talk between alpha(4)beta(1)/alpha(5)beta(1) and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways.

  2001cited by this paper
• Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice

  2000cited by this paper
• Integrin-Mediated Survival Signals Regulate the Apoptotic Function of Bax through Its Conformation and Subcellular Localization

  2000cited by this paper
• Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells.

  2000cited by this paper
• Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells.

  2000cited by this paper
• Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy.

  2000cited by this paper
• Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels

  2000cited by this paper
• Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid

  1999cited by this paper
• Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.

  1999cited by this paper
• Acute myeloid leukemia.

  1999cited by this paper
• Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system.

  1999cited by this paper
• Fibronectin interaction with α4β1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax

  1999cited by this paper
• Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia

  1999cited by this paper
• Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax.

  1999cited by this paper
• The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

  1998cited by this paper
• Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals

  1998cited by this paper
• A Strong Expression of CD 44-6 v Correlates With Shorter Survival of Patients With Acute Myeloid Leukemia

  1998cited by this paper
• A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia.

  1998cited by this paper
• Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion‐dependent cell survival

  1998cited by this paper
• Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia

  1997cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper
• Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation

  1997cited by this paper
• Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council.

  1997cited by this paper
• Neuroprotective Action of Cycloheximide Involves Induction of Bcl-2 and Antioxidant Pathways

  1997cited by this paper
• Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway

  1997cited by this paper
• Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.

  1996cited by this paper
• Critical amino acid residues for ligand binding are clustered in a predicted beta‐turn of the third N‐terminal repeat in the integrin alpha 4 and alpha 5 subunits.

  1995cited by this paper
• Identification of putative ligand-binding sites of the integrin α4β1 (VLA-4, CD49d/CD29)

  1995cited by this paper
• Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29)

  1995cited by this paper
• Integrin-mediated cell adhesion activates mitogen-activated protein kinases.

  1994cited by this paper
• Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5

  1994cited by this paper
• A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

  1994cited by this paper
• Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group.

  1993cited by this paper
• Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms.

  1993cited by this paper
• Concerted evolution in the GAPDH family of retrotransposed pseudogenes

  1993cited by this paper
• Randomized study of individualized induction therapy with or without vincristine, and of maintenance—intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML‐87 study of the Japan adult leukemia study group

  1993cited by this paper
• Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture

  1992cited by this paper
• VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

  1990cited by this paper
• VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

  1990cited by this paper
• Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization

  1989cited by this paper
• Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapse.

  1989cited by this paper
• The frequency of long‐term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow‐up time of 6 years

  1989cited by this paper
• Ligation of the CD 44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells

  year unknowncited by this paper

• Cytokines, Signaling and Epigenetic Mechanisms: Shaping the Acute Lymphoblastic Leukemia Microenvironment

  2026cites this paper
• iHALT unlocks liver functionality as a surrogate secondary lymphoid organ

  2025influential citation
• Research progress on Anoikis in hematological diseases: a literature review

  2025cites this paper
• PIEZO1 activity promotes stemness in mesenchymal stem cells under shear stress and enhances protection of leukemia cells

  2025cites this paper
• Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells

  2025cites this paper
• From Chemotherapy to Targeted Therapy: Unraveling Resistance in Acute Myeloid Leukemia Through Genetic and Non-Genetic Insights

  2025cites this paper
• DNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1+ T-Lineage Cancers.

  2025cites this paper
• Sonidegib Inhibits the Adhesion of Acute Myeloid Leukemia to the Bone Marrow in Hypoxia: An Optical Tweezer Study

  2025cites this paper
• Preclinical targeting of leukemia-initiating cells in the development future biologics for acute myeloid leukemia

  2025cites this paper
• TGF-β Decreases NK Cell Mobility and Cytotoxic Efficacy in Complex in vitro Models of the Leukemia Microenvironment

  2025cites this paper
• A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug Resistance

  2025cites this paper
• A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia

  2024cites this paper
• Dynamic Localization of Leukemia Stem Cells via CXCL12 Regulates Leukemia Progression

  2024cites this paper
• Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia

  2024cites this paper
• Targeting the bone marrow niche, moving towards leukemia eradication

  2024cites this paper
• Mesenchymal stromal cells as cancer promoters

  2024cites this paper
• Effect of Hydrogel Stiffness on Chemoresistance of Breast Cancer Cells in 3D Culture

  2024cites this paper
• Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression

  2024cites this paper
• Are we ready to integrate 3D culture systems in acute myeloid leukemia and bone marrow microenvironment research?

  2024cites this paper
• Imaging Very Late Antigen-4 on MOLT4 Leukemia Tumors with Cysteine Site-Specific 89Zr-Labeled Natalizumab Immuno-Positron Emission Tomography.

  2024cites this paper
• A novel in-vitro model of the bone marrow microenvironment in AML identifies CD44 and Focal Adhesion Kinase as therapeutic targets to reverse cell adhesion-mediated drug resistance

  2024cites this paper
• Unveiling cancer dormancy: intrinsic mechanisms and extrinsic forces.

  2024cites this paper
• Integrin-deficient T cell leukemia accumulates in the central nervous system

  2024cites this paper
• A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia

  2024cites this paper
• Protein‐Nanocaged Selenium Induces t(8;21) Leukemia Cell Differentiation via Epigenetic Regulation

  2023cites this paper
• Acute myeloid leukemia in elderly patients: New targets, new therapies

  2023cites this paper
• Understanding and targeting resistance mechanisms in cancer

  2023cites this paper
• Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance

  2023cites this paper
• High Throughput Fluorescence-Based In Vitro Experimental Platform for the Identification of Effective Therapies to Overcome Tumour Microenvironment-Mediated Drug Resistance in AML

  2023cites this paper
• Expansion of interferon inducible gene pool via USP18 inhibition promotes cancer cell pyroptosis

  2023cites this paper
• Targeting integrins in drug‐resistant acute myeloid leukaemia

  2023cites this paper
• Mechanobiology of cancer cell responsiveness to chemotherapy and immunotherapy: mechanistic insights and biomaterial platforms.

  2023cites this paper
• Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance.

  2023cites this paper
• Microenvironment in Acute Myeloid Leukemia: focus on senescence mechanisms, therapeutic interactions and future directions.

  2023cites this paper
• Understanding the interaction between leukaemia stem cells and their microenvironment to improve therapeutic approaches

  2023cites this paper
• Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity

  2023cites this paper
• Graphdiyne oxide nanosheets display selective anti-leukemia efficacy against DNMT3A-mutant AML cells

  2022cites this paper
• Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches

  2022cites this paper
• Implications of glutathione-S transferase P1 in MAPK signaling as a CRAF chaperone: In memory of Dr. Irving Listowsky

  2022cites this paper
• LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation

  2022cites this paper
• Human acute myeloid leukemia stem cells: evolution of concept

  2022cites this paper
• Endothelial cells: major players in acute myeloid leukaemia.

  2022cites this paper
• Bone Marrow Aging and the Leukaemia-Induced Senescence of Mesenchymal Stem/Stromal Cells: Exploring Similarities

  2022cites this paper
• FEV Maintains Homing and Expansion by Activating ITGA4 Transcription in Primary and Relapsed AML

  2022cites this paper
• Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia

  2022influential citation
• METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4

  2022cites this paper
• Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis

  2022cites this paper
• Leukemic stem cells and advances in hematopoietic stem cell transplantation for acute myeloid leukemia: a narrative review of clinical trials

  2022cites this paper
• Leukemic Stem Cells as a Target for Eliminating Acute Myeloid Leukemia: Gaps in Translational Research.

  2022cites this paper
• Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents.

  2022cites this paper
• Modelling acute myeloid leukemia (AML): What’s new? A transition from the classical to the modern

  2022cites this paper
• Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias

  2022cites this paper
• VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells

  2022cites this paper
• The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting

  2022cites this paper
• Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia

  2021cites this paper
• In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemia

  2021cites this paper
• Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?

  2021cites this paper
• Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities

  2021cites this paper
• BACH2‐mediated FOS confers cytarabine resistance via stromal microenvironment alterations in pediatric ALL

  2021cites this paper
• Biological Therapies in the Treatment of Cancer—Update and New Directions

  2021cites this paper
• MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer

  2021cites this paper
• Membrane-bound SCF and VCAM-1 synergistically regulate the morphology of hematopoietic stem cells

  2021cites this paper
• Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy

  2021cites this paper
• Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity

  2021cites this paper
• In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PET

  2021cites this paper
• VLA-4 Induces Chemoresistance of T Cell Acute Lymphoblastic Leukemia Cells via PYK2-Mediated Drug Efflux

  2021cites this paper
• Leukaemia: a model metastatic disease

  2021cites this paper
• Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter

  2021cites this paper
• Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia

  2021cites this paper
• miRNAs Mediated Drug Resistance in Hematological Malignancies.

  2021cites this paper
• Autophagy a Close Relative of AML Biology

  2021cites this paper
• The Role of Notch and Wnt Signaling in MSC Communication in Normal and Leukemic Bone Marrow Niche

  2021cites this paper
• Mesenchymal Stromal Cells as a Cellular Target in Myeloid Malignancy: Chances and Challenges in the Genome Editing of Stromal Alterations

  2021cites this paper
• Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development

  2021cites this paper
• Does the Chemotherapy Protocol Affect CXCL12/CXCR4 Axes in Acute Myeloid Leukemia Patients with Monocytic Differentiation?

  2021cites this paper
• Dissecting the role of the CXCL12/CXCR4 axis in Acute Myeloid Leukaemia

  2021cites this paper
• Remodeling of Bone Marrow Niches and Roles of Exosomes in Leukemia

  2021cites this paper
• Integrin α7 and Extracellular Matrix Laminin 211 Interaction Promotes Proliferation of Acute Myeloid Leukemia Cells and Is Associated with Granulocytic Sarcoma

  2020cites this paper
• Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia.

  2020cites this paper
• The extracellular matrix: A key player in the pathogenesis of hematologic malignancies.

  2020cites this paper
• Cancer Stem Cells in Pheochromocytoma and Paraganglioma

  2020cites this paper
• Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy.

  2020cites this paper
• Identification of a Prognostic Gene Signature Associated with Microenvironment in Acute Myeloid Leukemia

  2020cites this paper
• Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma

  2020cites this paper
• Bone marrow niches in haematological malignancies

  2020cites this paper
• Chemo/radiotherapy-Induced Bone Marrow Niche Alterations

  2020cites this paper
• Cadherins, Selectins, and Integrins in CAM-DR in Leukemia

  2020cites this paper
• A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia

  2020cites this paper
• Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias

  2020cites this paper
• Group I p21-activated kinases in leukemia cell adhesion to fibronectin

  2020cites this paper
• The choroid plexus stroma constitutes a sanctuary for paediatric B‐cell precursor acute lymphoblastic leukaemia in the central nervous system

  2020cites this paper
• HSOA Journal of Stem Cells Research, Development and Therapy Expression, Functions and Potential Therapeutic Implications of CD157 in Acute Myeloid Leukemia

  2020cites this paper
• Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The “Seed and Soil” Crosstalk

  2020cites this paper
• Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment

  2020cites this paper
• Study on Polyethylene Glycol Cross-linker in Peptide-conjugated Antibody on Efficiency of Cell Capture and Release.

  2020cites this paper
• Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia

  2020cites this paper
• Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches

  2020cites this paper
• Targeting BACH2-FOS signaling overcomes chemoresistance via stromal microenvironment alterations in pediatric acute lymphoblastic leukemia

  2020cites this paper
• Integrin expression and adhesivity to fibronectin in primary acute myeloid leukemia cells: Impact of NPM1 and FLT3 mutations

  2020cites this paper
• Redistribution, Homing and Organ-Invasion of Neoplastic Stem Cells in Myeloid Neoplasms.

  2020cites this paper